8 Lysine Vasopressin,
8-Lysine Vasopressin,
Diapid,
Lypressin,
Lys Vasopressin,
Lys-Vasopressin,
Lysine Vasopressin,
Lysyl Vasopressin,
Postacton,
Vasopressin, 8-Lysine,
Vasopressin, Lysine,
Vasopressin, Lysyl,
LYPRESSIN,
Lysine vasopressin,
Syntopressin,
Lysine pitressin,
Lysipressin,
Postacton,
50-57-7,
L-Lysine vasopressin,
Vasopressin-8-lysine,
8-L-Lysinevasopressin,
Vasopressin, 8-L-lysine-,
UNII-7CZF3L922Y,
Diapid,
(8-Lysine)vasopressin,
Lysine-vasopressin,
Vasopressin (lysine form),
8-L-Lysine vasopressin,
7CZF3L922Y,
Lipressina [DCIT],
[Lys8]-Vasopressin,
[8-Lysine]vasopressin,
Lipresina [INN-Spanish],
Lypressine [INN-French],
Lypressinum [INN-Latin],
Lysipressin acetate,
DSSTox_CID_28501,
DSSTox_RID_82773,
DSSTox_GSID_48575,
L-Cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1->6)-disulfide,
Lipressina,
Lypressine,
Lypressinum,
Lysopressin,
Lipresina,
Lysylvasopressin,
EINECS 200-050-5,
(Lys8)-Vasopressin,
BRN 4648365,
CAS-50-57-7,
3-(Phenylalanine)-8-lysine oxytocin,
L-lysinamide,,
Lysine-ADH,
Lypressin [USAN:USP:INN:BAN],
NCGC00181743-01,
NCGC00181743-02,
C46H65N13O12S2,
[Lys8]AVP,
AC1LD8IK,
SCHEMBL33287,
GTPL2172,
CHEMBL1200690,
DTXSID8048575,
CHEBI:94802,
BJFIDCADFRDPIO-DZCXQCEKSA-N,
HY-P0004,
L-Cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysylglycinamide cyclic (1-6)-disulfide,
LVP,
Tox21_112902,
Tox21_113427,
CL-017,
MFCD00076754,
AKOS030529559,
CS-5838,
FT-0656049,
Oxytocin, 3-(L-phenylalanine)-8-L-lysine-,
Vasopressin, 8-L-lysine- (7CI,8CI,9CI),
l]carbonyl]-L-prolyl-N-(2-amino-2-oxoethyl)-,
076L754,
BRD-K93331255-001-01-2,
1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane-10-propionamide,
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2[Disulfide Bridge: 1-6],
(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide,
(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide,
(2S)-N-[(2S)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentazacycloeicos-4-yl]-oxomethyl]-2-pyrrolidinecarboxamide,
1-[[(4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-13-(phenylmethyl)-1,2-dithia-5,8,11,14,17-pentaazacycloeicos-4-y,
1-{[(4R,7S,10S,13S,16S,19R)-19-Amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosan-4-yl]carbonyl}-L-p rolyl-L-lysylglycinamide,
19-amino-4-[2-[[5-amino-1-[(carbamoylmethyl)carbamoyl]pentyl]carbamoyl]-1-pyrrolidinylcarbonyl]-13-benzyl-7-(carbamoylmethyl)-16-p-hydroxybenzyl-6,9,12,15,18-pentaoxo- (6CI),
Glycinamide, L-cysteinyl-L-tyrosyl-L-phenylalanyl-L-glutaminyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-lysyl-, cyclic (1>6)-disulfide,
Pitressin,
Vasophysin,
Vasopressin,
Lypressin Acetate,
Schweine-Vasopressin,
Lysine-8-vasopressin,
D09PZZ,
Lypressin [USAN:BAN:INN],
Lypressin [USAN:INN:BAN],
CID644076,
CMC_13286,
ACN-049469,
C46-H65-N13-O12-S2,
1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane, cyclic peptide deriv.,
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfidebridge: Cys1-Cys6),
L-8,
L 8,